Search
News
Important Only
Other
Gain Therapeutics Completes Target Enrollment in Phase 1b GT-02287 Study for Parkinson’s with or without GBA1 Mutation
June 30 (Reuters) - Gain Therapeutics Inc GANX.O:GAIN THERAPEUTICS ANNOUNCES COMPLETION OF TARGET ENROLLMENT IN PHASE 1B CLINICAL STUDY EVALUATING GT-02287 IN PEOPLE WITH PARKINSON’S DISEASE WITH OR WITHOUT A GBA1 MUTATIONGAIN THERAPEUTICS INC - BIOMARKER ANALYSIS EXPECTED IN 4Q 2025, EARLIER THAN P...Reuters
Mon, Jun 30
Stocks
LIVE MARKETS-US stocks rally, rack up strong quarterly gains
Main US indexes advanceTech leads S&P sector gainers; Cons Disc weakest groupDollar, crude decline; bitcoin edges up; gold up >1%US 10-Year Treasury yield falls to ~4.24%Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with...Reuters
Mon, Jun 30
Other
Yorkville Acquisition Closes $172.5M IPO, Fully Exercises Underwriters’ Over-Allotment Option
June 30 (Reuters) - Yorkville Acquisition Corp YORKU.O:YORKVILLE ACQUISITION CORP. ANNOUNCES CLOSING OF $172,500,000 INITIAL PUBLIC OFFERING, INCLUDING FULL EXERCISE OF UNDERWRITERS’ OVER-ALLOTMENT OPTIONReuters
Mon, Jun 30
Other
US embassy in Jerusalem eases travel restrictions on American government employees in Israel
June 30 (Reuters) - The U.S. embassy in Jerusalem said on Monday it has eased travel restrictions on U.S. government employees and family members due to "stable security environment in Israel," according to a post by the embassy on social media platform X.It said the decision comes as it clo...Reuters
Mon, Jun 30
Other
Nvent Electric Enters Into Second Amended And Restated Credit Agreement
June 30 (Reuters) - nVent Electric PLC NVT.N:NVENT ELECTRIC PLC - ENTERS INTO SECOND AMENDED AND RESTATED CREDIT AGREEMENT - SEC FILINGNVENT ELECTRIC PLC - FINANCE MAY INCREASE REVOLVING CREDIT FACILITY BY UP TO $300 MILLION - SEC FILINGReuters
Mon, Jun 30
Other
Neurogene Launches Registrational Trial Design for NGN-401 Gene Therapy in Rett Syndrome Study
June 30 (Reuters) - Neurogene Inc NGNE.O:NEUROGENE ANNOUNCES REGISTRATIONAL TRIAL DESIGN FOR EMBOLDEN™ STUDY OF NGN-401 GENE THERAPY FOR RETT SYNDROMENEUROGENE INC: REGISTRATIONAL TRIAL INITIATION ACTIVITIES UNDERWAYNEUROGENE INC: CASH RUNWAY EXTENDED INTO EARLY 2028Reuters
Mon, Jun 30
Other
L.B. Foster Company Completes Successful Amendment to its Revolving Credit Agreement
June 30 (Reuters) - L B Foster Co FSTR.O:L.B. FOSTER COMPANY COMPLETES SUCCESSFUL AMENDMENT TO ITS REVOLVING CREDIT AGREEMENTL B FOSTER CO - BORROWING CAPACITY EXPANDED TO $150 MILLION WITH $60 MILLION LOAN FEATUREL B FOSTER CO - FACILITY MATURITY EXTENDED TO JUNE 27, 2030Reuters
Mon, Jun 30
Other
Deals of the Day-Mergers and acquisitions
June 30 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:** Spain's BBVA BBVA.MC said it would move ahead with its hostile takeover bid for Sabadell SABE.MC despite the government effectively blocking it from fully merging with its smaller r...Reuters
Mon, Jun 30
Stocks
Industry First -- Supermicro Systems Certified by Intel for an Immersion Cooling Solution
Supermicro's BigTwin® Multi-Node Server with 5th Gen Intel® Xeon® Scalable Processors is now certified by Intel Server system design supports OCP immersion guidelines that enables industry-wide compatibility SAN JOSE, Calif., July 1, 2025 /PRNewswire/ -- Super Micro Computer, ...PR Newswire
Mon, Jun 30
Featured Tools
Top News
AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours
Nvidia Stock: Breaking Down Its Key Risk and Why It’s Still a Compelling Buy in 2026
Vanguard ETF Could Beat the S&P 500 Again in 2026 —— Why Investors Are Paying Attention
Dell Stock Analysis: Is It Still Undervalued and the Best AI Infrastructure Play by 2026?
Is Novo Nordisk Positioned for Recovery in 2026 Amid Rising Competition and AI Innovations?
Market Movers
Tradingkey
